Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
DLTx's founder is Timothy Furey.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Datacolor: Your Partner in Precision Color Control | Albert Busch , PRESIDENT & CEO of Datacolor
00:10:00
Strategic Accumulation and Retirement Planning with TPC
00:10:00
Opening up a world of opportunity|Noel Quinn,CEO, HSBC holdings USA Inc
00:10:00
Mike Ford on Building SiteMinder and Navigating the Hotel Tech Space | Mike Ford, Founder , SiteMinder Ltd.
00:10:00
Catalyst Metals: ASX Gold Producer's Solid Financial Performance and Volatile Costs
00:10:00
crypto companies with big ambitions and contrarian worldviews|Robert Leshner,Partner,Robot Ventures
00:10:00
"A company that provides value to its users by offering Props, ensuring users see tangible benefits in receiving them."
00:10:00
Arçelik CEO Hakan Bulgurlu on the Beko-Whirlpool Merger: A New Chapter in Appliance Industry Growth | Hakan Bulgurlu, CEO, Arçelik AS.
00:10:00
Learn about Pictet Asset Management USA from its CEO, Elizabeth Dillon, and delve deeper into our offerings on our website.
00:10:00
CEO Malcolm Wilson Talks Freight State and GXO's Strategies in a High-Rate Environment | Malcolm Wilson - CEO of GXO Logistics
00:10:00
C3 Metals: Exploring New Opportunities in Peru and Jamaica with Dan Simons
00:10:00
Discipline and Experience: Key to Success in Emerging Markets